FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tamoxifen citrate from Mylan Pharmaceuticals Inc., solidifying its generic product approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen citrate (tamoxifen citrate)

Snippet

SUPPL AP for TAMOXIFEN CITRATE (TAMOXIFEN CITRATE)